World J Virol. 2017 May 12;6(2):26-35. doi: 10.5501/wjv.v6.i2.26.
Structural and nucleic acid binding properties of hepatitis delta virus small antigen.
World journal of virology
Carolina Alves, Hong Cheng, João Paulo Tavanez, Ana Casaca, Severin Gudima, Heinrich Roder, Celso Cunha
Affiliations
Affiliations
- Carolina Alves, João Paulo Tavanez, Ana Casaca, Celso Cunha, Global Health and Tropical Medicine, GHTM, Instituto de Higiene e Medicina Tropical, IHMT, Universidade Nova de Lisboa, 1349-008 Lisboa, Portugal.
PMID: 28573087
PMCID: PMC5437381 DOI: 10.5501/wjv.v6.i2.26
Abstract
AIM: To further characterize the structure and nucleic acid binding properties of the 195 amino acid small delta antigen, S-HDAg, a study was made of a truncated form of S-HDAg, comprising amino acids 61-195 (∆60HDAg), thus lacking the domain considered necessary for dimerization and higher order multimerization.
METHODS: Circular dichroism, and nuclear magnetic resonance experiments were used to assess the structure of ∆60HDAg. Nucleic acid binding properties were investigated by gel retardation assays.
RESULTS: Results showed that the truncated ∆60HDAg protein is intrinsically disordered but compact, whereas the RNA binding domain, comprising residues 94-146, adopts a dynamic helical conformation. We also found that ∆60HDAg fails to multimerize but still contains nucleic acid binding activity, indicating that multimerization is not essential for nucleic acid binding. Moreover, in agreement with what has been previously reported for full-length protein, no apparent specificity was found for the truncated protein regarding nucleic acid binding.
CONCLUSION: Taken together these results allowed concluding that ∆60HDAg is intrinsically disordered but compact; ∆60HDAg is not a multimer but is still capable of nucleic acid binding albeit without apparent specificity.
Keywords: Circular dichroism; Delta antigen; Hepatitis delta virus; Intrinsically disordered protein; Nuclear magnetic resonance
Conflict of interest statement
Conflict-of-interest statement: The authors declare no conflicts of interest.
References
- Virology. 2010 Nov 25;407(2):333-40 - PubMed
- J Virol. 1988 Jun;62(6):1855-61 - PubMed
- J Virol. 2014 Jul;88(13):7402-11 - PubMed
- J Virol. 1999 Dec;73(12):10540-5 - PubMed
- Viruses. 2010 Jan;2(1):189-212 - PubMed
- Prog Clin Biol Res. 1987;234:97-103 - PubMed
- J Virol. 2004 Dec;78(23):13325-34 - PubMed
- Biochemistry. 1999 Dec 14;38(50):16424-31 - PubMed
- J Virol. 2009 May;83(9):4548-56 - PubMed
- J Virol. 2008 Oct;82(19):9409-16 - PubMed
- J Virol. 1994 May;68(5):2879-88 - PubMed
- J Virol. 1991 Aug;65(8):4057-62 - PubMed
- Prog Clin Biol Res. 1987;234:105-10 - PubMed
- Virology. 2004 Feb 5;319(1):60-70 - PubMed
- Annu Rev Biophys Biophys Chem. 1988;17:145-66 - PubMed
- J Hepatol. 2009 May;50(5):1043-50 - PubMed
- J Virol. 2008 Oct;82(19):9345-58 - PubMed
- J Virol. 1988 Jul;62(7):2403-10 - PubMed
- Int J Biochem Cell Biol. 2011 Aug;43(8):1090-103 - PubMed
- J Virol. 1998 Jun;72(6):4783-8 - PubMed
- Proteins. 2003;53 Suppl 6:566-72 - PubMed
- Structure. 1998 Jul 15;6(7):821-30 - PubMed
- Virol J. 2011 Jul 20;8:358 - PubMed
- J Magn Reson B. 1994 Jul;104(3):298-302 - PubMed
- RNA. 2009 Nov;15(11):1971-9 - PubMed
Publication Types
Grant support